

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 8.84347736 |
| 2 | proline metabolic process (GO:0006560) | 6.70768364 |
| 3 | embryonic process involved in female pregnancy (GO:0060136) | 5.99538340 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.79491036 |
| 5 | protein retention in ER lumen (GO:0006621) | 5.60063142 |
| 6 | establishment of apical/basal cell polarity (GO:0035089) | 5.29926246 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 5.10579000 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 5.10579000 |
| 9 | transcription from mitochondrial promoter (GO:0006390) | 4.86691893 |
| 10 | regulation of integrin activation (GO:0033623) | 4.72770538 |
| 11 | oxidative demethylation (GO:0070989) | 4.48890344 |
| 12 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.43121760 |
| 13 | establishment of monopolar cell polarity (GO:0061162) | 4.43121760 |
| 14 | regulation of translational fidelity (GO:0006450) | 4.37762649 |
| 15 | positive regulation of protein homooligomerization (GO:0032464) | 4.35634213 |
| 16 | regulation of protein homooligomerization (GO:0032462) | 4.21664848 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.21290222 |
| 18 | COPII vesicle coating (GO:0048208) | 4.19861247 |
| 19 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.18873366 |
| 20 | mannose metabolic process (GO:0006013) | 4.17241565 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.15153155 |
| 22 | embryonic placenta development (GO:0001892) | 4.11858399 |
| 23 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.03523455 |
| 24 | positive regulation of nuclease activity (GO:0032075) | 4.00891717 |
| 25 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.87349734 |
| 26 | 4-hydroxyproline metabolic process (GO:0019471) | 3.86170604 |
| 27 | intestinal cholesterol absorption (GO:0030299) | 3.85752132 |
| 28 | protein localization to endosome (GO:0036010) | 3.79922805 |
| 29 | cellular response to ATP (GO:0071318) | 3.79196532 |
| 30 | regulation of cholesterol homeostasis (GO:2000188) | 3.78800120 |
| 31 | mitochondrial DNA metabolic process (GO:0032042) | 3.74265741 |
| 32 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.73141036 |
| 33 | glandular epithelial cell development (GO:0002068) | 3.62744236 |
| 34 | regulation of nuclease activity (GO:0032069) | 3.60356420 |
| 35 | replication fork processing (GO:0031297) | 3.54506134 |
| 36 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.45411464 |
| 37 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.41392922 |
| 38 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.39294956 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.39098853 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36241584 |
| 41 | mitotic G1/S transition checkpoint (GO:0044819) | 3.31417775 |
| 42 | cellular response to unfolded protein (GO:0034620) | 3.29900790 |
| 43 | convergent extension (GO:0060026) | 3.25049398 |
| 44 | N-glycan processing (GO:0006491) | 3.24311556 |
| 45 | maternal placenta development (GO:0001893) | 3.23812567 |
| 46 | apoptotic cell clearance (GO:0043277) | 3.22974954 |
| 47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21226746 |
| 48 | negative regulation of Ras GTPase activity (GO:0034261) | 3.21121718 |
| 49 | ER-nucleus signaling pathway (GO:0006984) | 3.16726726 |
| 50 | protein heterotrimerization (GO:0070208) | 3.14832372 |
| 51 | apoptotic process involved in morphogenesis (GO:0060561) | 3.13152813 |
| 52 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.12500925 |
| 53 | G1 DNA damage checkpoint (GO:0044783) | 3.11954483 |
| 54 | negative regulation of protein oligomerization (GO:0032460) | 3.09427364 |
| 55 | cellular response to topologically incorrect protein (GO:0035967) | 3.08315148 |
| 56 | regulation of extracellular matrix disassembly (GO:0010715) | 3.07679588 |
| 57 | barbed-end actin filament capping (GO:0051016) | 3.07240825 |
| 58 | pinocytosis (GO:0006907) | 3.07182059 |
| 59 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.06837354 |
| 60 | anatomical structure regression (GO:0060033) | 3.00683537 |
| 61 | peptidyl-proline hydroxylation (GO:0019511) | 2.99249597 |
| 62 | basement membrane organization (GO:0071711) | 2.98300348 |
| 63 | detection of bacterium (GO:0016045) | 2.98069990 |
| 64 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.97923113 |
| 65 | trophectodermal cell differentiation (GO:0001829) | 2.97832822 |
| 66 | cellular zinc ion homeostasis (GO:0006882) | 2.95307318 |
| 67 | detection of other organism (GO:0098543) | 2.95210766 |
| 68 | response to peptidoglycan (GO:0032494) | 2.94815050 |
| 69 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.93756429 |
| 70 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92597666 |
| 71 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.91977985 |
| 72 | regulation of hippo signaling (GO:0035330) | 2.91193265 |
| 73 | negative regulation of cell cycle arrest (GO:0071157) | 2.89490986 |
| 74 | response to endoplasmic reticulum stress (GO:0034976) | 2.88751563 |
| 75 | dosage compensation (GO:0007549) | 2.88086110 |
| 76 | mRNA cleavage (GO:0006379) | 2.87614888 |
| 77 | response to muramyl dipeptide (GO:0032495) | 2.82184845 |
| 78 | response to laminar fluid shear stress (GO:0034616) | 2.80296783 |
| 79 | protein targeting to vacuole (GO:0006623) | 2.79498111 |
| 80 | protein targeting to lysosome (GO:0006622) | 2.79498111 |
| 81 | establishment of protein localization to vacuole (GO:0072666) | 2.79498111 |
| 82 | positive regulation of protein oligomerization (GO:0032461) | 2.78206285 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77641507 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 2.77641507 |
| 85 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77641507 |
| 86 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77641507 |
| 87 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77641507 |
| 88 | modulation by symbiont of host immune response (GO:0052553) | 2.77641507 |
| 89 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.76172772 |
| 90 | negative regulation of fatty acid transport (GO:2000192) | 2.71333974 |
| 91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71021968 |
| 92 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.70828876 |
| 93 | detection of external biotic stimulus (GO:0098581) | 2.70260709 |
| 94 | negative regulation of granulocyte differentiation (GO:0030853) | 2.70049330 |
| 95 | cellular response to zinc ion (GO:0071294) | 2.69529522 |
| 96 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69311266 |
| 97 | hypotonic response (GO:0006971) | 2.69278703 |
| 98 | activation of Rac GTPase activity (GO:0032863) | 2.68986405 |
| 99 | polarized epithelial cell differentiation (GO:0030859) | 2.68634291 |
| 100 | regulation of protein oligomerization (GO:0032459) | 2.67500539 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.66866522 |
| 102 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.66573253 |
| 103 | protein carboxylation (GO:0018214) | 2.65688866 |
| 104 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.65688866 |
| 105 | negative regulation of cell killing (GO:0031342) | 2.64694608 |
| 106 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64694608 |
| 107 | vesicle coating (GO:0006901) | 2.64379439 |
| 108 | regulation of podosome assembly (GO:0071801) | 2.63944003 |
| 109 | stress fiber assembly (GO:0043149) | 2.63641625 |
| 110 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62539210 |
| 111 | negative regulation of cartilage development (GO:0061037) | 2.61709496 |
| 112 | macroautophagy (GO:0016236) | 2.59978165 |
| 113 | protein hydroxylation (GO:0018126) | 2.59502620 |
| 114 | negative regulation of cell size (GO:0045792) | 2.58986190 |
| 115 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.58004211 |
| 116 | regulation of cell size (GO:0008361) | 2.57791819 |
| 117 | regulation of leukocyte degranulation (GO:0043300) | 2.57320561 |
| 118 | regulation of response to reactive oxygen species (GO:1901031) | 2.56870750 |
| 119 | alkaloid metabolic process (GO:0009820) | 2.56802478 |
| 120 | cellular response to lithium ion (GO:0071285) | 2.56313425 |
| 121 | DNA strand renaturation (GO:0000733) | 2.55246790 |
| 122 | low-density lipoprotein particle clearance (GO:0034383) | 2.53356261 |
| 123 | embryonic eye morphogenesis (GO:0048048) | 2.53000286 |
| 124 | GDP-mannose metabolic process (GO:0019673) | 2.52495311 |
| 125 | positive regulation of receptor recycling (GO:0001921) | 2.52005064 |
| 126 | positive regulation of histone deacetylation (GO:0031065) | 2.51451029 |
| 127 | urea cycle (GO:0000050) | 2.50420925 |
| 128 | positive regulation of extracellular matrix organization (GO:1903055) | 2.49755075 |
| 129 | valine metabolic process (GO:0006573) | 2.49567515 |
| 130 | positive thymic T cell selection (GO:0045059) | 2.48891946 |
| 131 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.48839129 |
| 132 | epithelial cell fate commitment (GO:0072148) | 2.47328469 |
| 133 | negative regulation of GTP catabolic process (GO:0033125) | 2.47090383 |
| 134 | negative regulation of GTPase activity (GO:0034260) | 2.47090383 |
| 135 | regulation of RNA export from nucleus (GO:0046831) | 2.46968484 |
| 136 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.46404284 |
| 137 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.46404284 |
| 138 | UV protection (GO:0009650) | 2.45878425 |
| 139 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.45615862 |
| 140 | detection of molecule of bacterial origin (GO:0032490) | 2.45078446 |
| 141 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.44475564 |
| 142 | modulation by symbiont of host cellular process (GO:0044068) | 2.44417113 |
| 143 | semaphorin-plexin signaling pathway (GO:0071526) | 2.42221840 |
| 144 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.41508953 |
| 145 | hyaluronan catabolic process (GO:0030214) | 2.40643928 |
| 146 | urea metabolic process (GO:0019627) | 2.38423640 |
| 147 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.38415616 |
| 148 | detection of biotic stimulus (GO:0009595) | 2.37739496 |
| 149 | NIK/NF-kappaB signaling (GO:0038061) | 2.33835007 |
| 150 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.33491966 |
| 151 | regulation of extracellular matrix organization (GO:1903053) | 2.32790229 |
| 152 | peptide catabolic process (GO:0043171) | 2.31386096 |
| 153 | cell-substrate junction assembly (GO:0007044) | 2.31227985 |
| 154 | macrophage activation involved in immune response (GO:0002281) | 2.30519336 |
| 155 | adhesion of symbiont to host (GO:0044406) | 2.29971011 |
| 156 | pentose-phosphate shunt (GO:0006098) | 2.29717009 |
| 157 | thymic T cell selection (GO:0045061) | 2.29666571 |
| 158 | complement activation, alternative pathway (GO:0006957) | 2.29253712 |
| 159 | modulation by virus of host process (GO:0019054) | 2.24746853 |
| 160 | positive regulation of phagocytosis (GO:0050766) | 2.24500263 |
| 161 | negative regulation of interleukin-8 production (GO:0032717) | 2.24057358 |
| 162 | adherens junction assembly (GO:0034333) | 2.22994002 |
| 163 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.22260692 |
| 164 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.20515438 |
| 165 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.20515438 |
| 166 | glycosphingolipid catabolic process (GO:0046479) | 2.20177264 |
| 167 | cell-substrate adherens junction assembly (GO:0007045) | 2.19825825 |
| 168 | focal adhesion assembly (GO:0048041) | 2.19825825 |
| 169 | regulation of phagocytosis (GO:0050764) | 2.19550481 |
| 170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.19096674 |
| 171 | nitrogen cycle metabolic process (GO:0071941) | 2.16766541 |
| 172 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.15866944 |
| 173 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.15695573 |
| 174 | skin morphogenesis (GO:0043589) | 2.14729080 |
| 175 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.14076258 |
| 176 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.13618193 |
| 177 | negative regulation of type 2 immune response (GO:0002829) | 2.13159777 |
| 178 | glucose catabolic process (GO:0006007) | 2.13029335 |
| 179 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.12619605 |
| 180 | regulation of apoptotic cell clearance (GO:2000425) | 2.12597467 |
| 181 | activation of JUN kinase activity (GO:0007257) | 2.12455896 |
| 182 | regulation of monocyte differentiation (GO:0045655) | 2.10372595 |
| 183 | negative regulation of viral release from host cell (GO:1902187) | 2.10219063 |
| 184 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.08906702 |
| 185 | regulation of mast cell degranulation (GO:0043304) | 2.08824208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68454165 |
| 2 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.50073007 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49137073 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.47791832 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.43791856 |
| 6 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.33158811 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.28057282 |
| 8 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.26472414 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.23639047 |
| 10 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.15654804 |
| 11 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.07680022 |
| 12 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.07680022 |
| 13 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.07680022 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.06340406 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05046661 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.04670612 |
| 17 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.04445472 |
| 18 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.03107045 |
| 19 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.98928025 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96297928 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86632535 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85801270 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83456071 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82062192 |
| 25 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.81348052 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78304133 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77060718 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76333711 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75239746 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75062186 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73004130 |
| 32 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.72506004 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70167435 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67366153 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67143724 |
| 36 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.63864802 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62885297 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61377617 |
| 39 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.61262135 |
| 40 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.60582664 |
| 41 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.59877833 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59391084 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57794924 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55837819 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53832658 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53538888 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53280690 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52864184 |
| 49 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.51937985 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51475033 |
| 51 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.50688548 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50646253 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.48387809 |
| 54 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.48095688 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47778238 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47707739 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44840608 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44804961 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43564184 |
| 60 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43005287 |
| 61 | * MAF_26560356_Chip-Seq_TH2_Human | 1.41999195 |
| 62 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.40605161 |
| 63 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.40128515 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39200661 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39124147 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38714793 |
| 67 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37882094 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37642168 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36929224 |
| 70 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34801482 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34076262 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.33660850 |
| 73 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.33586420 |
| 74 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32991596 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30722390 |
| 76 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30547491 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29774812 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29220948 |
| 79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28317619 |
| 80 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.27018374 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25820776 |
| 82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24671600 |
| 83 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.23883391 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23116436 |
| 85 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20831707 |
| 86 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20729231 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20673647 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19897468 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19261358 |
| 90 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19162108 |
| 91 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19011140 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18310715 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18067682 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17520977 |
| 95 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17412320 |
| 96 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17412293 |
| 97 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17299054 |
| 98 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.16925174 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16452426 |
| 100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16274146 |
| 101 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.15773968 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15672997 |
| 103 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.15542354 |
| 104 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13317060 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12646355 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12140552 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12094457 |
| 108 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11594644 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11158101 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 1.11064827 |
| 111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.11007231 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09341961 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09207693 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09113739 |
| 115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09066392 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07938969 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07728967 |
| 118 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07520061 |
| 119 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07211651 |
| 120 | MAF_26560356_Chip-Seq_TH1_Human | 1.07081885 |
| 121 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06349582 |
| 122 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06258193 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06029895 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06008977 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05833362 |
| 126 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.04421009 |
| 127 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04371926 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03967528 |
| 129 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03734203 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03311381 |
| 131 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03262675 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02881078 |
| 133 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02700380 |
| 134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02225051 |
| 135 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01499567 |
| 136 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.01488802 |
| 137 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01036870 |
| 138 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00881022 |
| 139 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00718270 |
| 140 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00343976 |
| 141 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00208517 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99742139 |
| 143 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99667250 |
| 144 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99159496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 3.77655619 |
| 2 | MP0009278_abnormal_bone_marrow | 3.16952597 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.10177647 |
| 4 | MP0003436_decreased_susceptibility_to | 2.86314332 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.75302111 |
| 6 | MP0005365_abnormal_bile_salt | 2.70567221 |
| 7 | MP0004233_abnormal_muscle_weight | 2.68428775 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.40937101 |
| 9 | MP0003303_peritoneal_inflammation | 2.33412307 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.28160631 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.27197672 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.21085996 |
| 13 | MP0005451_abnormal_body_composition | 2.16101825 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.12862777 |
| 15 | MP0001958_emphysema | 2.11115848 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.09682103 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.03710577 |
| 18 | MP0004858_abnormal_nervous_system | 2.03225937 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.96464109 |
| 20 | MP0008260_abnormal_autophagy | 1.94824925 |
| 21 | MP0008057_abnormal_DNA_replication | 1.93667129 |
| 22 | MP0005171_absent_coat_pigmentation | 1.90156826 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.87375009 |
| 24 | MP0005409_darkened_coat_color | 1.86419266 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.84605766 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 1.84061482 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.83808457 |
| 28 | MP0003091_abnormal_cell_migration | 1.75629457 |
| 29 | MP0005220_abnormal_exocrine_pancreas | 1.75316947 |
| 30 | MP0003045_fibrosis | 1.72088458 |
| 31 | MP0000858_altered_metastatic_potential | 1.65138530 |
| 32 | MP0002419_abnormal_innate_immunity | 1.64237258 |
| 33 | MP0003724_increased_susceptibility_to | 1.63801668 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.60796669 |
| 35 | MP0002009_preneoplasia | 1.60687966 |
| 36 | MP0005025_abnormal_response_to | 1.58392340 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.56522620 |
| 38 | MP0004947_skin_inflammation | 1.53110134 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.49782265 |
| 40 | MP0002269_muscular_atrophy | 1.48066182 |
| 41 | MP0003119_abnormal_digestive_system | 1.43130369 |
| 42 | MP0005257_abnormal_intraocular_pressure | 1.42789946 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.42578269 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.41316988 |
| 45 | MP0004272_abnormal_basement_membrane | 1.40044463 |
| 46 | MP0005360_urolithiasis | 1.39473008 |
| 47 | MP0000371_diluted_coat_color | 1.38555368 |
| 48 | MP0003252_abnormal_bile_duct | 1.37772287 |
| 49 | MP0001790_abnormal_immune_system | 1.37134793 |
| 50 | MP0005387_immune_system_phenotype | 1.37134793 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.36739191 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.36130573 |
| 53 | MP0009840_abnormal_foam_cell | 1.35372172 |
| 54 | MP0000462_abnormal_digestive_system | 1.33114417 |
| 55 | MP0006082_CNS_inflammation | 1.32590655 |
| 56 | MP0002060_abnormal_skin_morphology | 1.31499180 |
| 57 | MP0003329_amyloid_beta_deposits | 1.30517558 |
| 58 | MP0005666_abnormal_adipose_tissue | 1.30070872 |
| 59 | MP0004130_abnormal_muscle_cell | 1.29230526 |
| 60 | MP0005000_abnormal_immune_tolerance | 1.28802721 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.28350927 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.28155012 |
| 63 | MP0003890_abnormal_embryonic-extraembry | 1.27774477 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.27729372 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.26282416 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.24558040 |
| 67 | MP0001944_abnormal_pancreas_morphology | 1.23978708 |
| 68 | MP0000604_amyloidosis | 1.23210619 |
| 69 | MP0003828_pulmonary_edema | 1.20363255 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.19777976 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.19777976 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.19180335 |
| 73 | MP0005670_abnormal_white_adipose | 1.18806333 |
| 74 | MP0002933_joint_inflammation | 1.17846519 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 1.17225088 |
| 76 | MP0005083_abnormal_biliary_tract | 1.17211469 |
| 77 | MP0005275_abnormal_skin_tensile | 1.16102611 |
| 78 | MP0000609_abnormal_liver_physiology | 1.15261960 |
| 79 | MP0005023_abnormal_wound_healing | 1.14817470 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.14268486 |
| 81 | MP0004197_abnormal_fetal_growth/weight/ | 1.11131308 |
| 82 | MP0002166_altered_tumor_susceptibility | 1.10743840 |
| 83 | MP0002896_abnormal_bone_mineralization | 1.10072556 |
| 84 | MP0003075_altered_response_to | 1.08929539 |
| 85 | MP0009785_altered_susceptibility_to | 1.08728089 |
| 86 | MP0002452_abnormal_antigen_presenting | 1.08491413 |
| 87 | MP0000639_abnormal_adrenal_gland | 1.08298649 |
| 88 | MP0001800_abnormal_humoral_immune | 1.08090088 |
| 89 | MP0002420_abnormal_adaptive_immunity | 1.06153685 |
| 90 | MP0002723_abnormal_immune_serum | 1.06118674 |
| 91 | MP0001819_abnormal_immune_cell | 1.05756330 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 1.05704838 |
| 93 | MP0009384_cardiac_valve_regurgitation | 1.05622692 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 1.04966596 |
| 95 | MP0002693_abnormal_pancreas_physiology | 1.04940547 |
| 96 | MP0005390_skeleton_phenotype | 1.04643875 |
| 97 | MP0008961_abnormal_basal_metabolism | 1.03782317 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 1.03475456 |
| 99 | MP0005503_abnormal_tendon_morphology | 1.01926705 |
| 100 | MP0009115_abnormal_fat_cell | 1.01136883 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.99861143 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.99102660 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.98158664 |
| 104 | MP0003448_altered_tumor_morphology | 0.97097243 |
| 105 | MP0002084_abnormal_developmental_patter | 0.96594180 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.95798460 |
| 107 | MP0006054_spinal_hemorrhage | 0.95769047 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.95165967 |
| 109 | MP0002970_abnormal_white_adipose | 0.94826816 |
| 110 | MP0008469_abnormal_protein_level | 0.93812043 |
| 111 | MP0003195_calcinosis | 0.93673983 |
| 112 | MP0002118_abnormal_lipid_homeostasis | 0.93585694 |
| 113 | MP0002396_abnormal_hematopoietic_system | 0.92757318 |
| 114 | MP0002796_impaired_skin_barrier | 0.92682720 |
| 115 | MP0005164_abnormal_response_to | 0.92608992 |
| 116 | MP0004510_myositis | 0.91828494 |
| 117 | MP0010630_abnormal_cardiac_muscle | 0.91372570 |
| 118 | MP0004133_heterotaxia | 0.90770828 |
| 119 | MP0001873_stomach_inflammation | 0.90205339 |
| 120 | MP0002405_respiratory_system_inflammati | 0.90174275 |
| 121 | MP0000470_abnormal_stomach_morphology | 0.88655185 |
| 122 | MP0000579_abnormal_nail_morphology | 0.88596894 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.88505324 |
| 124 | MP0001697_abnormal_embryo_size | 0.87452257 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.86852042 |
| 126 | MP0000249_abnormal_blood_vessel | 0.86573825 |
| 127 | MP0000751_myopathy | 0.86507667 |
| 128 | MP0003959_abnormal_lean_body | 0.85925416 |
| 129 | MP0001851_eye_inflammation | 0.85859367 |
| 130 | MP0004883_abnormal_blood_vessel | 0.85077857 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.84645889 |
| 132 | MP0004381_abnormal_hair_follicle | 0.84292294 |
| 133 | MP0005330_cardiomyopathy | 0.83736044 |
| 134 | MP0005508_abnormal_skeleton_morphology | 0.83191681 |
| 135 | MP0004808_abnormal_hematopoietic_stem | 0.82351881 |
| 136 | MP0003866_abnormal_defecation | 0.82310544 |
| 137 | MP0002111_abnormal_tail_morphology | 0.82294643 |
| 138 | MP0002168_other_aberrant_phenotype | 0.82055067 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.81224455 |
| 140 | MP0000716_abnormal_immune_system | 0.80924783 |
| 141 | MP0005332_abnormal_amino_acid | 0.80637525 |
| 142 | MP0000678_abnormal_parathyroid_gland | 0.80634769 |
| 143 | MP0002282_abnormal_trachea_morphology | 0.80372887 |
| 144 | MP0000598_abnormal_liver_morphology | 0.80372154 |
| 145 | MP0002653_abnormal_ependyma_morphology | 0.79686972 |
| 146 | MP0001849_ear_inflammation | 0.79550435 |
| 147 | MP0005166_decreased_susceptibility_to | 0.79412253 |
| 148 | MP0000681_abnormal_thyroid_gland | 0.78743017 |
| 149 | MP0002398_abnormal_bone_marrow | 0.77756867 |
| 150 | MP0002971_abnormal_brown_adipose | 0.77484596 |
| 151 | MP0004043_abnormal_pH_regulation | 0.77287672 |
| 152 | MP0009780_abnormal_chondrocyte_physiolo | 0.76894962 |
| 153 | MP0002085_abnormal_embryonic_tissue | 0.76525612 |
| 154 | MP0002132_abnormal_respiratory_system | 0.75145988 |
| 155 | MP0003279_aneurysm | 0.71662499 |
| 156 | MP0010307_abnormal_tumor_latency | 0.71056607 |
| 157 | MP0001672_abnormal_embryogenesis/_devel | 0.70086220 |
| 158 | MP0005380_embryogenesis_phenotype | 0.70086220 |
| 159 | MP0004087_abnormal_muscle_fiber | 0.69025963 |
| 160 | MP0000685_abnormal_immune_system | 0.68796838 |
| 161 | MP0003656_abnormal_erythrocyte_physiolo | 0.68324796 |
| 162 | MP0008995_early_reproductive_senescence | 0.67743494 |
| 163 | MP0002108_abnormal_muscle_morphology | 0.67351912 |
| 164 | MP0004019_abnormal_vitamin_homeostasis | 0.67317689 |
| 165 | MP0002837_dystrophic_cardiac_calcinosis | 0.66650208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mucopolysacchariduria (HP:0008155) | 4.58375254 |
| 2 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.58375254 |
| 3 | Turricephaly (HP:0000262) | 4.42851280 |
| 4 | Cerebral aneurysm (HP:0004944) | 4.37663067 |
| 5 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.17290636 |
| 6 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.17290636 |
| 7 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.17290636 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.06899389 |
| 9 | Ulnar bowing (HP:0003031) | 3.89443367 |
| 10 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.75763585 |
| 11 | Large for gestational age (HP:0001520) | 3.62381432 |
| 12 | Ketoacidosis (HP:0001993) | 3.39956927 |
| 13 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.36364956 |
| 14 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.36364956 |
| 15 | Alopecia of scalp (HP:0002293) | 3.29770804 |
| 16 | Asymmetric septal hypertrophy (HP:0001670) | 3.19790271 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.17136021 |
| 18 | Pustule (HP:0200039) | 3.11485059 |
| 19 | Hemorrhage of the eye (HP:0011885) | 3.03197956 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.01612686 |
| 21 | Vertebral compression fractures (HP:0002953) | 2.95685614 |
| 22 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.93809995 |
| 23 | Rib fusion (HP:0000902) | 2.93399003 |
| 24 | Thin bony cortex (HP:0002753) | 2.93281842 |
| 25 | Hypoglycemic coma (HP:0001325) | 2.87107312 |
| 26 | Joint stiffness (HP:0001387) | 2.82481126 |
| 27 | Facial hemangioma (HP:0000329) | 2.79776025 |
| 28 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.71017053 |
| 29 | Vertebral hypoplasia (HP:0008417) | 2.71017053 |
| 30 | Polycythemia (HP:0001901) | 2.70097970 |
| 31 | Male infertility (HP:0003251) | 2.70079090 |
| 32 | Growth hormone excess (HP:0000845) | 2.69417316 |
| 33 | Abnormality of complement system (HP:0005339) | 2.68100734 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.67789701 |
| 35 | Hypercortisolism (HP:0001578) | 2.65262954 |
| 36 | Hypochromic microcytic anemia (HP:0004840) | 2.61713831 |
| 37 | Annular pancreas (HP:0001734) | 2.60666071 |
| 38 | Coronal craniosynostosis (HP:0004440) | 2.59868646 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55526119 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55526119 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55526119 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.51351721 |
| 43 | Hypoglycemic seizures (HP:0002173) | 2.48777381 |
| 44 | Ketosis (HP:0001946) | 2.48230965 |
| 45 | Abnormal hemoglobin (HP:0011902) | 2.47566475 |
| 46 | Bowed forearm bones (HP:0003956) | 2.47501613 |
| 47 | Bowing of the arm (HP:0006488) | 2.47501613 |
| 48 | Broad face (HP:0000283) | 2.46576680 |
| 49 | Orthostatic hypotension (HP:0001278) | 2.44721130 |
| 50 | Cellulitis (HP:0100658) | 2.42491729 |
| 51 | Short humerus (HP:0005792) | 2.42337436 |
| 52 | Premature rupture of membranes (HP:0001788) | 2.38622951 |
| 53 | Aneurysm (HP:0002617) | 2.37540310 |
| 54 | Myocardial infarction (HP:0001658) | 2.35730882 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33566010 |
| 56 | Complement deficiency (HP:0004431) | 2.33394619 |
| 57 | Concave nail (HP:0001598) | 2.32633650 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.32028302 |
| 59 | Premature skin wrinkling (HP:0100678) | 2.29577072 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.28127501 |
| 61 | Poikiloderma (HP:0001029) | 2.27486701 |
| 62 | Peritonitis (HP:0002586) | 2.26344194 |
| 63 | Vaginal fistula (HP:0004320) | 2.25294104 |
| 64 | Muscle fibrillation (HP:0010546) | 2.24853009 |
| 65 | Dilatation of the ascending aorta (HP:0005111) | 2.24363139 |
| 66 | Congenital hip dislocation (HP:0001374) | 2.21612397 |
| 67 | Hyperacusis (HP:0010780) | 2.20379279 |
| 68 | Congenital glaucoma (HP:0001087) | 2.18265140 |
| 69 | Generalized amyotrophy (HP:0003700) | 2.15805067 |
| 70 | Gingivitis (HP:0000230) | 2.14975899 |
| 71 | Dysautonomia (HP:0002459) | 2.14613103 |
| 72 | Metaphyseal cupping (HP:0003021) | 2.13744057 |
| 73 | Atrophic scars (HP:0001075) | 2.13462540 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.13459813 |
| 75 | Fragile skin (HP:0001030) | 2.13320215 |
| 76 | Emphysema (HP:0002097) | 2.12784388 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12382173 |
| 78 | Tongue fasciculations (HP:0001308) | 2.11684817 |
| 79 | Aortic aneurysm (HP:0004942) | 2.10961924 |
| 80 | Late onset (HP:0003584) | 2.10781033 |
| 81 | Increased CSF protein (HP:0002922) | 2.10694082 |
| 82 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.10217566 |
| 83 | Purpura (HP:0000979) | 2.09423288 |
| 84 | Rectal fistula (HP:0100590) | 2.09120996 |
| 85 | Rectovaginal fistula (HP:0000143) | 2.09120996 |
| 86 | Hypertriglyceridemia (HP:0002155) | 2.08320765 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.08266960 |
| 88 | Achilles tendon contracture (HP:0001771) | 2.07826433 |
| 89 | Biconcave vertebral bodies (HP:0004586) | 2.06636457 |
| 90 | Flat acetabular roof (HP:0003180) | 2.04767349 |
| 91 | Hand muscle atrophy (HP:0009130) | 2.04488885 |
| 92 | Hyperglycemia (HP:0003074) | 2.04345533 |
| 93 | Malnutrition (HP:0004395) | 2.04270599 |
| 94 | J-shaped sella turcica (HP:0002680) | 2.03993052 |
| 95 | Wormian bones (HP:0002645) | 2.02575597 |
| 96 | Myositis (HP:0100614) | 2.02174068 |
| 97 | Aortic dissection (HP:0002647) | 2.01580125 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 2.01292047 |
| 99 | Intestinal fistula (HP:0100819) | 2.01161937 |
| 100 | Disproportionate tall stature (HP:0001519) | 2.00955601 |
| 101 | Amyloidosis (HP:0011034) | 2.00799801 |
| 102 | Abnormality of the thoracic spine (HP:0100711) | 2.00361302 |
| 103 | Obstructive sleep apnea (HP:0002870) | 1.99969964 |
| 104 | Vascular tortuosity (HP:0004948) | 1.99907346 |
| 105 | Anteriorly placed anus (HP:0001545) | 1.99615134 |
| 106 | Back pain (HP:0003418) | 1.97687420 |
| 107 | Hypoplastic ischia (HP:0003175) | 1.97587841 |
| 108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97571795 |
| 109 | Thoracic kyphosis (HP:0002942) | 1.96656853 |
| 110 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.96575803 |
| 111 | Loss of speech (HP:0002371) | 1.94750856 |
| 112 | Polygenic inheritance (HP:0010982) | 1.94609246 |
| 113 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94517987 |
| 114 | Exocrine pancreatic insufficiency (HP:0001738) | 1.92941524 |
| 115 | Coarse hair (HP:0002208) | 1.92452989 |
| 116 | Stridor (HP:0010307) | 1.92084857 |
| 117 | Glomerulonephritis (HP:0000099) | 1.91695532 |
| 118 | Increased IgM level (HP:0003496) | 1.91327183 |
| 119 | Diaphragmatic weakness (HP:0009113) | 1.91010939 |
| 120 | Mitral regurgitation (HP:0001653) | 1.90591705 |
| 121 | Insulin resistance (HP:0000855) | 1.90516785 |
| 122 | Joint hemorrhage (HP:0005261) | 1.90281389 |
| 123 | Arterial tortuosity (HP:0005116) | 1.89273625 |
| 124 | Spondylolisthesis (HP:0003302) | 1.89200998 |
| 125 | Hyperparathyroidism (HP:0000843) | 1.88845309 |
| 126 | Blue sclerae (HP:0000592) | 1.88811739 |
| 127 | Upper limb amyotrophy (HP:0009129) | 1.88266135 |
| 128 | Distal upper limb amyotrophy (HP:0007149) | 1.88266135 |
| 129 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.87865463 |
| 130 | Gastrointestinal inflammation (HP:0004386) | 1.87668105 |
| 131 | Deep venous thrombosis (HP:0002625) | 1.87308579 |
| 132 | Increased IgE level (HP:0003212) | 1.85993700 |
| 133 | Choanal stenosis (HP:0000452) | 1.85139619 |
| 134 | Distal lower limb muscle weakness (HP:0009053) | 1.84412492 |
| 135 | Abnormality of the nasal mucosa (HP:0000433) | 1.84370576 |
| 136 | Epistaxis (HP:0000421) | 1.83140568 |
| 137 | Distal lower limb amyotrophy (HP:0008944) | 1.82696559 |
| 138 | Bladder diverticulum (HP:0000015) | 1.82484106 |
| 139 | Xanthomatosis (HP:0000991) | 1.82030860 |
| 140 | Intrahepatic cholestasis (HP:0001406) | 1.80350227 |
| 141 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80321022 |
| 142 | Lower limb hyperreflexia (HP:0002395) | 1.79622932 |
| 143 | Abnormality of the intrinsic pathway (HP:0010989) | 1.78535332 |
| 144 | Spontaneous hematomas (HP:0007420) | 1.77813375 |
| 145 | Abnormality of the ischium (HP:0003174) | 1.77566188 |
| 146 | Albinism (HP:0001022) | 1.76740373 |
| 147 | Obstructive lung disease (HP:0006536) | 1.76562147 |
| 148 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76562147 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76138872 |
| 150 | Shallow orbits (HP:0000586) | 1.76071727 |
| 151 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75592218 |
| 152 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74780967 |
| 153 | Symptomatic seizures (HP:0011145) | 1.74685081 |
| 154 | Short chin (HP:0000331) | 1.73612866 |
| 155 | Myoglobinuria (HP:0002913) | 1.73589418 |
| 156 | Gastrointestinal infarctions (HP:0005244) | 1.72849788 |
| 157 | Mitral stenosis (HP:0001718) | 1.72777314 |
| 158 | Spinal rigidity (HP:0003306) | 1.72756831 |
| 159 | Gastrointestinal dysmotility (HP:0002579) | 1.72592997 |
| 160 | Abnormality of the lower motor neuron (HP:0002366) | 1.71371520 |
| 161 | Ankle contracture (HP:0006466) | 1.70691680 |
| 162 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.69851267 |
| 163 | Mitral valve prolapse (HP:0001634) | 1.69683855 |
| 164 | Nephritis (HP:0000123) | 1.69682784 |
| 165 | Macroorchidism (HP:0000053) | 1.69455324 |
| 166 | Prolonged bleeding time (HP:0003010) | 1.69407537 |
| 167 | Alacrima (HP:0000522) | 1.67122758 |
| 168 | Genu recurvatum (HP:0002816) | 1.66325260 |
| 169 | Cervical subluxation (HP:0003308) | 1.65959975 |
| 170 | Hamartoma (HP:0010566) | 1.65426591 |
| 171 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65137178 |
| 172 | Increased connective tissue (HP:0009025) | 1.65007340 |
| 173 | Mediastinal lymphadenopathy (HP:0100721) | 1.63951666 |
| 174 | Inflammation of the large intestine (HP:0002037) | 1.63345646 |
| 175 | Colitis (HP:0002583) | 1.62748623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 4.68419400 |
| 2 | MAPK15 | 4.47888467 |
| 3 | DDR2 | 4.13982026 |
| 4 | TRIB3 | 3.68166011 |
| 5 | PDGFRA | 2.96838641 |
| 6 | PRPF4B | 2.88135263 |
| 7 | MAP3K6 | 2.81045809 |
| 8 | ERN1 | 2.71569725 |
| 9 | SMG1 | 2.45868089 |
| 10 | MAP3K11 | 2.38492282 |
| 11 | TYRO3 | 2.19463134 |
| 12 | MATK | 2.04161255 |
| 13 | PKN2 | 2.01123418 |
| 14 | BMX | 1.97051063 |
| 15 | DYRK1B | 1.96156819 |
| 16 | PRKD2 | 1.91054642 |
| 17 | MAP3K10 | 1.90322240 |
| 18 | CSK | 1.84266926 |
| 19 | SIK1 | 1.82968693 |
| 20 | PINK1 | 1.74386365 |
| 21 | IRAK3 | 1.73479590 |
| 22 | TYK2 | 1.68291195 |
| 23 | FGR | 1.65295520 |
| 24 | UHMK1 | 1.57472476 |
| 25 | RIPK4 | 1.56380083 |
| 26 | TBK1 | 1.55509989 |
| 27 | RIPK1 | 1.46922130 |
| 28 | BCKDK | 1.39356033 |
| 29 | HIPK2 | 1.34543647 |
| 30 | FLT3 | 1.34309693 |
| 31 | BLK | 1.34184713 |
| 32 | DAPK1 | 1.32069605 |
| 33 | EEF2K | 1.31331432 |
| 34 | MAP3K13 | 1.30052997 |
| 35 | MST1R | 1.29958462 |
| 36 | CDK6 | 1.25484214 |
| 37 | SCYL2 | 1.22651060 |
| 38 | INSRR | 1.20995193 |
| 39 | GRK6 | 1.20899498 |
| 40 | PTK6 | 1.19922542 |
| 41 | TAOK3 | 1.19153408 |
| 42 | JAK3 | 1.17645197 |
| 43 | MTOR | 1.17089949 |
| 44 | CDC42BPA | 1.17022268 |
| 45 | TRPM7 | 1.16228890 |
| 46 | LATS1 | 1.13622539 |
| 47 | TESK1 | 1.13191102 |
| 48 | PIM2 | 1.12314178 |
| 49 | GSK3A | 1.10735537 |
| 50 | IRAK4 | 1.09783764 |
| 51 | RPS6KA2 | 1.08714582 |
| 52 | NME2 | 1.07702981 |
| 53 | MAP3K14 | 1.06293373 |
| 54 | TNK2 | 1.04823722 |
| 55 | TAOK2 | 1.04726211 |
| 56 | PDPK1 | 1.02982080 |
| 57 | KIT | 1.01231891 |
| 58 | PTK2 | 1.00729024 |
| 59 | PASK | 1.00457366 |
| 60 | TESK2 | 0.99973753 |
| 61 | LATS2 | 0.99039121 |
| 62 | MAPK11 | 0.95998649 |
| 63 | TTN | 0.94667149 |
| 64 | RPS6KC1 | 0.93720193 |
| 65 | RPS6KL1 | 0.93720193 |
| 66 | CDK12 | 0.91326140 |
| 67 | FGFR4 | 0.88988635 |
| 68 | CSF1R | 0.88985391 |
| 69 | FES | 0.88786925 |
| 70 | PDGFRB | 0.87099727 |
| 71 | CDK7 | 0.86580648 |
| 72 | RPS6KA6 | 0.80501719 |
| 73 | PRKAA1 | 0.78938714 |
| 74 | BTK | 0.77885202 |
| 75 | AKT3 | 0.77578766 |
| 76 | PIM1 | 0.75844868 |
| 77 | PHKG1 | 0.74940226 |
| 78 | PHKG2 | 0.74940226 |
| 79 | MAPKAPK3 | 0.73528093 |
| 80 | PAK2 | 0.70246094 |
| 81 | EPHB1 | 0.69715168 |
| 82 | KSR2 | 0.65602351 |
| 83 | MAPK12 | 0.65532817 |
| 84 | YES1 | 0.64084950 |
| 85 | SIK2 | 0.64007206 |
| 86 | IKBKE | 0.63434985 |
| 87 | HCK | 0.62311518 |
| 88 | MAPK7 | 0.61887044 |
| 89 | JAK2 | 0.61737615 |
| 90 | FGFR3 | 0.61574765 |
| 91 | MET | 0.60983338 |
| 92 | ARAF | 0.60823612 |
| 93 | LMTK2 | 0.60273052 |
| 94 | PRKG2 | 0.59950044 |
| 95 | PDK1 | 0.59931485 |
| 96 | PAK4 | 0.59446011 |
| 97 | NEK9 | 0.58848477 |
| 98 | DMPK | 0.58550377 |
| 99 | EPHA2 | 0.57830729 |
| 100 | FRK | 0.57801834 |
| 101 | MAP3K7 | 0.57490871 |
| 102 | PRKD3 | 0.56970922 |
| 103 | RPS6KA1 | 0.55822803 |
| 104 | KDR | 0.55583497 |
| 105 | TAOK1 | 0.55575376 |
| 106 | PRKD1 | 0.55076894 |
| 107 | TGFBR2 | 0.53323471 |
| 108 | ALK | 0.52370034 |
| 109 | CDK4 | 0.51758621 |
| 110 | LRRK2 | 0.51291222 |
| 111 | IRAK2 | 0.51103874 |
| 112 | CAMK1D | 0.47977272 |
| 113 | MAP2K2 | 0.47750362 |
| 114 | EGFR | 0.47136449 |
| 115 | STK38 | 0.45011166 |
| 116 | PRKAA2 | 0.44659460 |
| 117 | NTRK1 | 0.44059717 |
| 118 | SYK | 0.43775147 |
| 119 | MAP3K8 | 0.43669992 |
| 120 | MOS | 0.41275577 |
| 121 | STK3 | 0.40561246 |
| 122 | MAP3K1 | 0.38502483 |
| 123 | RPS6KB2 | 0.38112444 |
| 124 | MARK2 | 0.37314505 |
| 125 | PRKCH | 0.36557139 |
| 126 | MAP3K2 | 0.35993818 |
| 127 | STK10 | 0.35027759 |
| 128 | FER | 0.34609152 |
| 129 | RET | 0.33939929 |
| 130 | MAP3K3 | 0.33876246 |
| 131 | MAP4K1 | 0.32195869 |
| 132 | MAPK1 | 0.31909320 |
| 133 | FGFR1 | 0.31767675 |
| 134 | INSR | 0.31344188 |
| 135 | MAPK3 | 0.29963534 |
| 136 | EPHA3 | 0.28724554 |
| 137 | ZAP70 | 0.27265712 |
| 138 | DYRK3 | 0.24512894 |
| 139 | MAP2K3 | 0.23296154 |
| 140 | JAK1 | 0.23078431 |
| 141 | RPS6KB1 | 0.21352827 |
| 142 | PRKACG | 0.20498880 |
| 143 | MAPKAPK2 | 0.20361996 |
| 144 | CAMK1G | 0.19989675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.46305899 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.83778522 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.42768181 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.27158602 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26379122 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.09219447 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.08873255 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.98803405 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.94088726 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78300609 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.76084000 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72588065 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 1.68126726 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60061553 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57630875 |
| 16 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.52850708 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.52316517 |
| 18 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.49959945 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49611510 |
| 20 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.47210586 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47159357 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45328173 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41679423 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41110127 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41050346 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.40688251 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39130713 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.38901280 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36421646 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34815354 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32647372 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32333989 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31508732 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23959167 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23245937 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23081720 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19723576 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18722507 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17286650 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16375717 |
| 41 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.15201048 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14472626 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13808468 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13507375 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.13454846 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13201674 |
| 47 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.11230586 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.11121691 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.09720557 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 1.09260382 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.06576784 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05410924 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.04666380 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 1.03797781 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02183827 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01593663 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00892291 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98951292 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.97861097 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.97623596 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97250312 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96395974 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96377537 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96319557 |
| 65 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94308109 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93995631 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93059147 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92567571 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92192663 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92130306 |
| 71 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.91725058 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.90190256 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88787987 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88545523 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84760055 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83713229 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.83321532 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83222060 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82566677 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82271858 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81558152 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81492172 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.81307620 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80837674 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80463807 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77599856 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77246755 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.76627651 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76094912 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76008680 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75517202 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.74389023 |
| 93 | Allograft rejection_Homo sapiens_hsa05330 | 0.73285902 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73088327 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73042077 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.73012835 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72151297 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71964337 |
| 99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71948455 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.71034879 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69947254 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69087604 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67914307 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.67281221 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67197743 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66570126 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66246568 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65141716 |
| 109 | Measles_Homo sapiens_hsa05162 | 0.63973176 |
| 110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63625855 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62637672 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62411194 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62330566 |
| 114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62024478 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60279885 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59370139 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59088341 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58930874 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58732522 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58535542 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58222967 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58169765 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57943070 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57164337 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56736303 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56539091 |
| 127 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56134947 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55937398 |
| 129 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55847789 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55807390 |
| 131 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55764669 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55609307 |
| 133 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55251117 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55216891 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.54756208 |
| 136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54004007 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53606522 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52995428 |
| 139 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52786965 |
| 140 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52691037 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51476204 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.51147326 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51012383 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50719013 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.50378742 |
| 146 | Tight junction_Homo sapiens_hsa04530 | 0.50171188 |
| 147 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49994949 |
| 148 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49191890 |
| 149 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48091410 |
| 150 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47821770 |
| 151 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47617041 |
| 152 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47039632 |
| 153 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46460193 |
| 154 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45427243 |
| 155 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45085815 |
| 156 | Shigellosis_Homo sapiens_hsa05131 | 0.44074801 |
| 157 | Amoebiasis_Homo sapiens_hsa05146 | 0.42632773 |
| 158 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42495421 |

